ArticleJournal of thoracic disease2018
Clinical implications of the innovations in the primary tumour and metastasis of the 8
Article in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality Registry.JTO clinical and research reports · 2026Article
- Article
- T4 Lung Carcinoma with Infiltration of the Thoracic Aorta: Indication and Surgical Procedure.Cancers · 2023Review
- How Natural Language Processing Can Aid With Pulmonary Oncology Tumor Node Metastasis Staging From Free-Text Radiology Reports: Algorithm Development and Validation.JMIR formative research · 2023Article
- Article
- Systematic endoscopic staging of mediastinum to determine impact on radiotherapy for locally advanced lung cancer (SEISMIC): protocol for a prospective single arm multicentre interventional study.BMC pulmonary medicine · 2022Article
- The prognostic utility of the histologic subtype of stage I lung adenocarcinoma may be diminished when using only the invasive component to determine tumor size for tumor node metastasis (TNM) staging.Journal of thoracic disease · 2021Article
- Genome-wide analysis of long non-coding RNA expression profile in lung adenocarcinoma compared to spinal metastasis.Annals of translational medicine · 2020Article
- The Effect of Resection Margin Distance and Invasive Component Size on Recurrence After Sublobar Resection in Patients With Small (≤2 Cm) Lung Adenocarcinoma.World journal of surgery · 2020Article
- External validation of the eighth edition of the TNM classification for lung cancer in 3,611 surgically treated patients at a single institution.Annals of translational medicine · 2020Article
- Prognostic Factors in Stage IIB Non-Small Cell Lung Cancer according to the 8th Edition of TNM Staging System.The Korean journal of thoracic and cardiovascular surgery · 2019Article
- Prognosis after wedge resection in patients with 8Journal of thoracic disease · 2019Article
- Risk analysis of visceral pleural invasion in malignant solitary pulmonary nodules that appear touching the pleural surface.Therapeutic advances in respiratory diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 8th edition of the tumour, node and metastasis (TNM) classification for lung cancer introduced two new categories to accommodate adenocarcinoma in situ (AIS)-Tis(AIS)-and minimally invasive adenocarcinoma-T1mi; subdivided T1 into T1a (≤1 cm), T1b (>1-2 cm) and T1c (>2-3 cm); and T2 into T2a (>3-4 cm) and T2b (>4-5 cm); reclassified tumours >5-7 cm as T3, and those >7 cm as T4; reclassified endobronchial location <2 cm from the carina and total atelectasis/pneumonitis as T2a; and reclassified invasion of the diaphragm as T4. Regarding metastasis, the 7
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.